Cytogenetic response to autografting in chronic myelogenous leukemia correlates with the amount of BCR-ABL positive cells in the graft
- 1 January 2000
- journal article
- clinical trial
- Published by Elsevier in Experimental Hematology
- Vol. 28 (1) , 104-111
- https://doi.org/10.1016/s0301-472x(99)00135-6
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Quantitative competitive reverse transcriptase-polymerase chain reaction for BCR-ABL on Philadelphia-negative leukaphereses allows the selection of low-contaminated peripheral blood progenitor cells for autografting in chronic myelogenous leukemiaLeukemia, 1999
- Autografting With Philadelphia Chromosome–Negative Mobilized Hematopoietic Progenitor Cells in Chronic Myelogenous LeukemiaBlood, 1999
- Comparative Analysis of Autografting in Chronic Myelogenous Leukemia: Effects of Priming Regimen and Marrow or Blood Origin of Stem CellsBlood, 1998
- Peripheral blood progenitor cells mobilized early at diagnosis in patients with chronic myelogenous leukemia contain very low amounts of BCR-ABL transcriptsLeukemia, 1998
- Chemotherapy-induced mobilization of karyotypically normal PBSC for autografting in CMLBone Marrow Transplantation, 1998
- Quality of IL-3 and G-CSF-mobilized peripheral blood stem cells in patients with early chronic phase CMLLeukemia, 1998
- Mobilization and transplantation of Philadelphia-negative peripheral-blood progenitor cells early in chronic myelogenous leukemia.Journal of Clinical Oncology, 1997
- Treatment of chronic myeloid leukaemia in first chronic phase with idarubicin and cytarabine: mobilization of Philadelphia‐negative peripheral blood stem cellsBritish Journal of Haematology, 1997
- Autologous transplants for chronic myelogenous leukaemia: results from eight transplant groupsThe Lancet, 1994
- Early detection of relapse after bone marrow transplantation in patients with chronic myelogenous leukaemiaThe Lancet, 1993